Dopaminergic Supersensitivity Factors in Tourette's Syndrome: A Hypothesis
- 1 January 1989
- journal article
- review article
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 44 (1-2) , 169-174
- https://doi.org/10.3109/00207458908986195
Abstract
Alterations in striatal dopamine receptor functions are thought to underlie the major symptoms of Tourette's syndrome (TS). In this communication, evidence is presented to suggest that the striatal dopamine receptor supersensitivity in TS may be mediated by alterations in the release and function of dopamine supersensitive factors including prolactin, estrogens, beta-endorphin, melanocyte stimulating hormone (MSH), and adrenal corticotrophic hormone (ACTH). It is suggested that treatment of TS should be directed towards rectifying these endocrine and neuropeptide imbalances.Keywords
This publication has 22 references indexed in Scilit:
- Postural Asymmetry and Movement Disorder After Unilateral Microinjection of Adrenocorticotropin 1-24 in Rat BrainstemScience, 1982
- Possible DA Agonist Properties of NaloxoneInternational Journal of Neuroscience, 1982
- Behavioral effects of ACTH and MSH peptidesJournal of Endocrinological Investigation, 1981
- Characterization of the striatal dopamine receptor supersensitivity produced by estrogen treatment of male ratsNeuropharmacology, 1980
- Hypophysectomy prevents the striatal dopamine receptor supersensitivity produced by chronic haloperidol treatmentEuropean Journal of Pharmacology, 1980
- Effects of Dopamine Agonists and Antagonists in Tourette's DiseaseArchives of General Psychiatry, 1979
- Enkephalins and nigrostriatal functionNeurology, 1978
- ŒSTROGENS AND EXTRAPYRAMIDAL SYSTEMThe Lancet, 1977
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Effect of Melanocyte-Stimulating Hormone-Release Inhibiting Factor (MIF) in Parkinson’s SyndromEuropean Neurology, 1974